Skip to main content
. 2022 Dec 15;9(12):808. doi: 10.3390/bioengineering9120808
ACT adoptive cell therapy
CAR-T cell chimeric antigen receptor T cell
GMP good manufacture practice
DC dendritic cell
EVA ethyl vinyl acetate
FEP fluorinated ethylene propylene
HFBR hollow-fiber bioreactor
MSCs mesenchymal stem cells
NK natural killer
PBL peripheral blood lymphocyte
PoC point-of-care
TIL tumor infiltrating lymphocyte